Title: The effects of globalisation on the pharmaceutical industry in emerging markets: the case of Turkey
Authors: M. Cagri Pehlivanoglu
Addresses: Business School, Brunel University, Uxbridge, UB8 3PH, London, UK
Abstract: Foreign Direct Investment (FDI) has become the most important determinant in the process of globalisation, and as such, it is changing the economies of many countries. The main objective of this research is to investigate the nature of FDI inflows into the Turkish pharmaceutical industry and examine whether local or multinational firms drive the changing market. The paper indicates that when considering FDI, potential benefits must be weighed against potential costs. It is recommended that countries be cautious about maintaining local producers while involving multinationals in their industries.
Keywords: globalisation; FDI; foreign direct investment; pharmaceutical industry; Turkey; emerging markets; local firms; multinational corporations; MNCs.
International Journal of Trade and Global Markets, 2010 Vol.3 No.3, pp.231 - 246
Published online: 26 Aug 2010 *Full-text access for editors Full-text access for subscribers Purchase this article Comment on this article